2008International Journal of Dermatology and VenereologyRequires access

Th17 cells and psoriasis

Yanhong Wang, Aie Xu

Open publisher page 0 citations

Abstract

Psoriasis is traditionally viewed as a chronic inflammatory skin disease driven by Th1 cellular immune response. Recently, a novel and unique subset of interleukin (IL)-17 producing CD4+ effector T (Th17) cells, which are distinct from Th1 and Th2 cells, have been discovered. It may be crucial in the pathogenesis of various chronic inflammatory diseases that were formerly categorized as Th1-mediated disorders including psoriasis. Th17 cells may play a more important role than Th1 cells in the pathogenesis of psoriasis. This paper presents the significance of Th17 cells in the pathogenesis of psoriasis as well as in the identification of potential targets for the treatment of psoriasis. Key words: Psoriasis;  CD4-positive T-lymphocytes

About this research paper

What this paper is about

Psoriasis is traditionally viewed as a chronic inflammatory skin disease driven by Th1 cellular immune response. Recently, a novel and unique subset of interleukin (IL)-17 producing CD4+ effector T (Th17) cells, which are distinct from Th1 and Th2 cells, have been discovered. It may be crucial in the pathogenesis of various chronic inflammatory diseases that were formerly categorized as Th1-mediated disorders including psoriasis. Th17 cells may play a more important role than Th1 cells in the pathogenesis of psoriasis. This paper presents the significance of Th17 cells in the pathogenesis of psoriasis as well as in the identification of potential targets for the treatment of psoriasis. Key words: Psoriasis;  CD4-positive T-lymphocytes

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Psoriasis is traditionally viewed as a chronic inflammatory skin disease driven by Th1 cellular immune response. Recently, a novel and unique subset of interleukin (IL)-17 producing CD4+ effector T (Th17) cells, which are distinct from Th1 and Th2 cells, have been discovered. It may be crucial in the pathogenesis of various chronic inflammatory diseases that were formerly categorized as Th1-mediated disorders including psoriasis. Th17 cells may play a more important role than Th1 cells in the pathogenesis of psoriasis. This paper presents the significance of Th17 cells in the pathogenesis of psoriasis as well as in the identification of potential targets for the treatment of psoriasis. Key words: Psoriasis;  CD4-positive T-lymphocytes

Key concepts: Psoriasis, Pathogenesis, Immunology, Immune system, Effector, Interleukin 17, Disease, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Th17 cells and psoriasis — Research Paper | ScholarLens